Kaizen Financial Strategies’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Kaizen Financial Strategies's LLY Position: Q2 2026 in Review
Kaizen Financial Strategies reduced its Eli Lilly (LLY) stake by 7.3% in Q2 2026, selling an estimated $119K and leaving 1,464 shares worth $1.75M. The position accounts for 0.57% of the portfolio, ranked #35.
Kaizen Financial Strategies first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.08M in Q3 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Kaizen Financial Strategies held 1,464 shares of Eli Lilly worth $1.75M as of Q2 2026.
- Kaizen Financial Strategies sold 116 Eli Lilly shares in Q2 2026, an estimated $119K.
- Eli Lilly made up 0.57% of Kaizen Financial Strategies's portfolio in Q2 2026, its #35 holding.
- Kaizen Financial Strategies first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
- Kaizen Financial Strategies's Eli Lilly position peaked at $2.08M in Q3 2025.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Kaizen Financial Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.